EXACT Sciences Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $78.5
- Today's High:
- $80.56
- Open Price:
- $79.42
- 52W Low:
- $29.27
- 52W High:
- $86
- Prev. Close:
- $79.77
- Volume:
- 720209
Company Statistics
- Market Cap.:
- $15.33 billion
- Book Value:
- 17.003
- Revenue TTM:
- $2.20 billion
- Operating Margin TTM:
- -22.87%
- Gross Profit TTM:
- $1.51 billion
- Profit Margin:
- -23.49%
- Return on Assets TTM:
- -4.92%
- Return on Equity TTM:
- -16.36%
Company Profile
EXACT Sciences Corporation had its IPO on 2001-02-01 under the ticker symbol EXAS.
The company operates in the Healthcare sector and Diagnostics & Research industry. EXACT Sciences Corporation has a staff strength of 6,300 employees.
Stock update
Shares of EXACT Sciences Corporation opened at $79.42 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $78.5 - $80.56, and closed at $78.59.
This is a -1.48% slip from the previous day's closing price.
A total volume of 720,209 shares were traded at the close of the day’s session.
In the last one week, shares of EXACT Sciences Corporation have slipped by -7.71%.
EXACT Sciences Corporation's Key Ratios
EXACT Sciences Corporation has a market cap of $15.33 billion, indicating a price to book ratio of 2.603 and a price to sales ratio of 3.9532.
In the last 12-months EXACT Sciences Corporation’s revenue was $2.20 billion with a gross profit of $1.51 billion and an EBITDA of $-303552992. The EBITDA ratio measures EXACT Sciences Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, EXACT Sciences Corporation’s operating margin was -22.87% while its return on assets stood at -4.92% with a return of equity of -16.36%.
In Q1, EXACT Sciences Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a positive 23.8%.
EXACT Sciences Corporation’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- -1.07
Its diluted EPS in the last 12-months stands at $-3 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -1.07. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into EXACT Sciences Corporation’s profitability.
EXACT Sciences Corporation stock is trading at a EV to sales ratio of 4.9219 and a EV to EBITDA ratio of -18.9372. Its price to sales ratio in the trailing 12-months stood at 3.9532.
EXACT Sciences Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $6.30 billion
- Total Liabilities
- $367.35 million
- Operating Cash Flow
- $82.94 million
- Capital Expenditure
- $29.36 million
- Dividend Payout Ratio
- 0%
EXACT Sciences Corporation ended 2025 with $6.30 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $6.30 billion while shareholder equity stood at $3.06 billion.
EXACT Sciences Corporation ended 2025 with $0 in deferred long-term liabilities, $367.35 million in other current liabilities, 1799000.00 in common stock, $-3339177000.00 in retained earnings and $2.35 billion in goodwill. Its cash balance stood at $421.37 million and cash and short-term investments were $698.65 million. The company’s total short-term debt was $30,014,000 while long-term debt stood at $2.36 billion.
EXACT Sciences Corporation’s total current assets stands at $1.09 billion while long-term investments were $0 and short-term investments were $277.28 million. Its net receivables were $183.37 million compared to accounts payable of $86.71 million and inventory worth $124.09 million.
In 2025, EXACT Sciences Corporation's operating cash flow was $82.94 million while its capital expenditure stood at $29.36 million.
Comparatively, EXACT Sciences Corporation paid $0 in dividends in 2025.
Other key metrics
- Current Trading Price
- $78.59
- 52-Week High
- $86
- 52-Week Low
- $29.27
- Analyst Target Price
- $84.18
EXACT Sciences Corporation stock is currently trading at $78.59 per share. It touched a 52-week high of $86 and a 52-week low of $86. Analysts tracking the stock have a 12-month average target price of $84.18.
Its 50-day moving average was $88.31 and 200-day moving average was $72.29 The short ratio stood at 4.98 indicating a short percent outstanding of 0%.
Around 91.7% of the company’s stock are held by insiders while 8822.3% are held by institutions.
Frequently Asked Questions About EXACT Sciences Corporation
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company’s pipeline products focus on enhancing the Cologuard test’s performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.